Foundations Investment Advisors, LLC
EndowmentPosition in NNVC — Nanoviricides, Inc.
CIK 1743404
PHOENIX, AZ
Position in NNVC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,104
-$2,196 QoQ
Shares Held
10,005
+0.1% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Foundations Investment Advisors, LLC holds $3,744,351 across 9 Biotechnology names. NNVC ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
54,004 | $1,641,721 | |
| 2 | EXEL |
Exelixis, Inc.
|
18,912 | $811,135 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,164 | $519,772 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
32,259 | $247,426 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293 | $226,383 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
3,901 | $220,367 | |
| 7 | ACHV |
Achieve Life Sciences, Inc.
|
11,702 | $34,403 | |
| 8 | ALT |
Altimmune, Inc.
|
11,052 | $34,040 |
All Filings in NNVC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,104 | 10,005 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,300 | 10,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $14,300 | 10,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $14,000 | 10,000 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||